163 related articles for article (PubMed ID: 10797232)
1. Mutational analysis of the structure and function of opioid receptors.
Law PY; Wong YH; Loh HH
Biopolymers; 1999; 51(6):440-55. PubMed ID: 10797232
[TBL] [Abstract][Full Text] [Related]
2. Molecular recognition of opioid receptor ligands.
Kane BE; Svensson B; Ferguson DM
AAPS J; 2006 Mar; 8(1):E126-37. PubMed ID: 16584119
[TBL] [Abstract][Full Text] [Related]
3. Recombinant opioid receptors. Structure-function relationship.
Filipovska J; Gomes I; Xu W; Chen C; Liu-Chen LY; Devi LA
Methods Mol Med; 2003; 84():185-203. PubMed ID: 12703324
[No Abstract] [Full Text] [Related]
4. Structure and regulation of opioid receptors.
Chaturvedi K; Christoffers KH; Singh K; Howells RD
Biopolymers; 2000; 55(4):334-46. PubMed ID: 11169924
[TBL] [Abstract][Full Text] [Related]
5. [Molecular biological study on structure and function of the opioid receptor].
Fukuda K
Masui; 1996 Sep; 45(9):1060-66. PubMed ID: 8905940
[TBL] [Abstract][Full Text] [Related]
6. Complementarity of delta opioid ligand pharmacophore and receptor models.
Mosberg HI
Biopolymers; 1999; 51(6):426-39. PubMed ID: 10797231
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of 4-(N,N-diarylamino)piperidines with high selectivity to the delta-opioid receptor: a combined 3D-QSAR and ligand docking study.
Podlogar BL; Poda GI; Demeter DA; Zhang SP; Carson JR; Neilson LA; Reitz AB; Ferguson DM
Drug Des Discov; 2000; 17(1):34-50. PubMed ID: 10928448
[TBL] [Abstract][Full Text] [Related]
8. Cross-chimeric analysis of selectivity of secretin and VPAC(1) receptor activation.
Park CG; Ganguli SC; Pinon DI; Hadac EM; Miller LJ
J Pharmacol Exp Ther; 2000 Nov; 295(2):682-8. PubMed ID: 11046106
[TBL] [Abstract][Full Text] [Related]
9. Extracellular loop 3 (ECL3) and ECL3-proximal transmembrane domains VI and VII of the mesotocin and vasotocin receptors confer differential ligand selectivity and signaling activity.
Cho HJ; Moon MJ; Kwon HB; Hwang JI; Seong JY
Gen Comp Endocrinol; 2008 Mar; 156(1):71-82. PubMed ID: 18158152
[TBL] [Abstract][Full Text] [Related]
10. Structural mimicry in G protein-coupled receptors: implications of the high-resolution structure of rhodopsin for structure-function analysis of rhodopsin-like receptors.
Ballesteros JA; Shi L; Javitch JA
Mol Pharmacol; 2001 Jul; 60(1):1-19. PubMed ID: 11408595
[TBL] [Abstract][Full Text] [Related]
11. Josef Rudinger Memorial Lecture 2002. The chemistry of the opioid receptor binding sites.
Medzihradszky K
J Pept Sci; 2003 Jun; 9(6):333-53. PubMed ID: 12846480
[TBL] [Abstract][Full Text] [Related]
12. Engineering and functional immobilization of opioid receptors.
Ott D; Neldner Y; Cèbe R; Dodevski I; Plückthun A
Protein Eng Des Sel; 2005 Mar; 18(3):153-60. PubMed ID: 15790572
[TBL] [Abstract][Full Text] [Related]
13. Structural determinants for selective recognition of peptide ligands for endothelin receptor subtypes ETA and ETB.
Lättig J; Oksche A; Beyermann M; Rosenthal W; Krause G
J Pept Sci; 2009 Jul; 15(7):479-91. PubMed ID: 19466696
[TBL] [Abstract][Full Text] [Related]
14. Functional cartography of the ectodomain of the type I interferon receptor subunit ifnar1.
Lamken P; Gavutis M; Peters I; Van der Heyden J; Uzé G; Piehler J
J Mol Biol; 2005 Jul; 350(3):476-88. PubMed ID: 15946680
[TBL] [Abstract][Full Text] [Related]
15. Effects of the substitution of Phe4 in the opioid peptide [D-Ala8]dynorphin A-(1-11)NH2.
Vig BS; Zheng MQ; Murray TF; Aldrich JV
J Med Chem; 2003 Sep; 46(19):4002-8. PubMed ID: 12954053
[TBL] [Abstract][Full Text] [Related]
16. Opioid receptor oligomerization. Detection and functional characterization of interacting receptors.
Gomes I; Filipovska J; Devi LA
Methods Mol Med; 2003; 84():157-83. PubMed ID: 12703323
[No Abstract] [Full Text] [Related]
17. Structural insights into the ligand binding domains of membrane bound guanylyl cyclases and natriuretic peptide receptors.
van den Akker F
J Mol Biol; 2001 Aug; 311(5):923-37. PubMed ID: 11556325
[TBL] [Abstract][Full Text] [Related]
18. Building novel binding ligands to B7.1 and B7.2 based on human antibody single variable light chain domains.
van den Beucken T; van Neer N; Sablon E; Desmet J; Celis L; Hoogenboom HR; Hufton SE
J Mol Biol; 2001 Jul; 310(3):591-601. PubMed ID: 11439026
[TBL] [Abstract][Full Text] [Related]
19. Peptide interactions with G-protein coupled receptors.
Marshall GR
Biopolymers; 2001; 60(3):246-77. PubMed ID: 11774230
[TBL] [Abstract][Full Text] [Related]
20. Complex of an active mu-opioid receptor with a cyclic peptide agonist modeled from experimental constraints.
Fowler CB; Pogozheva ID; Lomize AL; LeVine H; Mosberg HI
Biochemistry; 2004 Dec; 43(50):15796-810. PubMed ID: 15595835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
